Renal and Cardiovascular Effects of sodium–glucose cotransporter 2 (SGLT2) inhibition in combination with loop Diuretics in diabetic patients with Chronic Heart Failure (RECEDE-CHF): protocol for a randomised controlled double-blind cross-over trial

INTRODUCTION: Type 2 diabetes (T2D) and heart failure (HF) are a frequent combination, where treatment options remain limited. There has been increasing interest around the sodium–glucose cotransporter 2 (SGLT2) inhibitors and their use in patients with HF. Data on the effect of SGLT2 inhibitor use...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMJ Open
Главные авторы: Mordi, Natalie A, Mordi, Ify R, Singh, Jagdeep S, Baig, Fatima, Choy, Anna-Maria, McCrimmon, Rory J, Struthers, Allan D, Lang, Chim C
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2017
Предметы:
Cardiovascular Medicine
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652490/
https://ncbi.nlm.nih.gov/pubmed/29042392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2017-018097
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы